Alignment Healthcare, Inc. ALHC
NASDAQ · United States · Health Services
$8.16+0.25 (+3.16%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Alignment Healthcare has seen its share price fall sharply this year, and the swing has pushed investors to focus more squarely on what the current market value implies about its earnings power. With the stock under pressure, the key issue is whether today's valuation still lines up with what the business is actually generating from its Medicare Advantage operations. The share price is down 56.9% year to date, which puts a lot of weight on whether the current market value matches what...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Regulatory shock puts Alignment Healthcare in focus Lawmakers have introduced the Protecting Approved Care Act, targeting how Medicare Advantage plans handle prior authorizations and payment clawbacks, and Alignment Healthcare (ALHC) quickly came under pressure as investors weighed potential margin effects. The regulatory headline comes on top of a sharp shift in sentiment around Alignment Healthcare. The share price is down 19.86% over the past day, 51.59% over 90 days and 48.71% year to...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.